Wird geladen...
The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
The BCL-2 protein family members inhibit cellular apoptosis, and their overexpression represents a common survival adaption in cancer. Recently, a selective BCL-2 inhibitor ABT-199, venetoclax, has demonstrated remarkable activity in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic...
Gespeichert in:
| Veröffentlicht in: | Blood Lymphat Cancer |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859801/ https://ncbi.nlm.nih.gov/pubmed/32009829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S177009 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|